Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders. Last week the CJEU published its keenly awaited judgments concerning several well-known pharmaceutical companies which provide guidance for parallel traders of medicines.
Key points
Opening a medicine’s packaging in order to comply with EU regulations in the import country can leave visible traces. Such traces are not themselves sufficient to justify the parallel trader replacing...
November 22, 2022
8 min read